Do dietary calcium ıntake and hormone replacement therapy affect bone mineral density in women?
Yükleniyor...
Dosyalar
Tarih
2008
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: Bu çalışmada, kadınların diyetle kalsiyum alım düzeylerinin ve hormon replasman tedavisi (HRT) alma durumlarının menopoz sonrası kemik mineral yoğunluğu (KMY) ile ilişkisi araştırıldı. Hastalar ve Yöntemler: İki yüz menopoz sonrası kadın (ort. yaş 58.89±8.51; dağılım 42-83) geriye dönük olarak değerlendirildi. Menopoz yaşı, menopoz süresi, HRT alıp almadığı ve diyetle kalsiyum alım düzeyleri kaydedildi. Kemik mineral yoğunluğu değerlendirmesi, lomber omurga ve femurdan Dual enerji X-ray absorbsiyometri (DEXA) cihazı kullanılarak yapıldı ve T skorları belirlendi. Bulgular: Hastaların yaşı ve menopoz süresi ile KMY arasında istatistiksel olarak anlamlı düzeyde negatif ilişki vardı. Hormon replasman tedavisi alanlarda, almayanlara göre KMY değerleri daha yüksekti. Diyetle kalsiyum alımı günlük 1000 mg’dan daha fazla olan kadınlarda omurga ve femur KMY değerleri, kalsiyum alımı 600 mg/gün ve 600-1000 mg/gün olan kadınlardan anlamlı derecede daha yüksekti. Sonuç: Menopoz sonrası kadınlarda diyetle alınan kalsiyum düzeyi ve HRT alım durumunun KMY açısından bir belirteç olabileceği düşünüldü.
Objectives: In this study, the relationship between postmenopausal bone mineral density (BMD), and hormone replacement therapy (HRT) and the level of dietary calcium intake in women was investigated. Patients and Methods: Two hundred postmenopausal women (mean age 58.89±8.51 years; range 42 to 83 years) were evaluated retrospectively. Menopausal age and duration, HRT status, and daily dietary calcium intake of all patients were recorded. Evaluation of BMD was made with Dual Energy X-Ray Absorptiometry (DEXA) from lumbar spine and femur and the T scores were obtained. Results: There was a significant negative correlation between the patients’ age and duration of menopause, and BMD. The BMD values of the patients not receiving HRT were significantly lower than those of the patients receiving HRT. In women with dietary calcium intake above 1000 mg/day, spine and femur BMD values were significantly higher than in those with an intake below 600 mg/ day and between 600-1000 mg/day. Conclusion: We think that dietary calcium intake and HRT status can be an indicator for BMD in postmenopausal women.
Objectives: In this study, the relationship between postmenopausal bone mineral density (BMD), and hormone replacement therapy (HRT) and the level of dietary calcium intake in women was investigated. Patients and Methods: Two hundred postmenopausal women (mean age 58.89±8.51 years; range 42 to 83 years) were evaluated retrospectively. Menopausal age and duration, HRT status, and daily dietary calcium intake of all patients were recorded. Evaluation of BMD was made with Dual Energy X-Ray Absorptiometry (DEXA) from lumbar spine and femur and the T scores were obtained. Results: There was a significant negative correlation between the patients’ age and duration of menopause, and BMD. The BMD values of the patients not receiving HRT were significantly lower than those of the patients receiving HRT. In women with dietary calcium intake above 1000 mg/day, spine and femur BMD values were significantly higher than in those with an intake below 600 mg/ day and between 600-1000 mg/day. Conclusion: We think that dietary calcium intake and HRT status can be an indicator for BMD in postmenopausal women.
Açıklama
Anahtar Kelimeler
Genel ve Dahili Tıp
Kaynak
Trakya Üniversitesi Tıp Fakültesi Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
25
Sayı
2
